HEADER TRANSCRIPTION 09-SEP-19 6SSQ TITLE CRYSTAL STRUCTURE OF RARBETA LBD IN COMPLEX WITH LG 100754 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RETINOIC ACID RECEPTOR BETA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: RAR-BETA,HBV-ACTIVATED PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 5 GROUP B MEMBER 2,RAR-EPSILON; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 9 CHAIN: F, G; COMPND 10 SYNONYM: NCOA-1,CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 74,BHLHE74, COMPND 11 PROTEIN HIN-2,RIP160,RENAL CARCINOMA ANTIGEN NY-REN-52,STEROID COMPND 12 RECEPTOR COACTIVATOR 1,SRC-1; COMPND 13 EC: 2.3.1.48; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RARB, HAP, NR1B2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: NCOA1, BHLHE74, SRC1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUCLEAR RECEPTOR, LIGAND BINDING, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR A.LE MAIRE,C.TEYSSIER,P.GERMAIN,W.BOURGUET REVDAT 2 24-JAN-24 6SSQ 1 JRNL REVDAT 1 20-NOV-19 6SSQ 0 JRNL AUTH A.LE MAIRE,C.TEYSSIER,P.BALAGUER,W.BOURGUET,P.GERMAIN JRNL TITL REGULATION OF RXR-RAR HETERODIMERS BY RXR- AND RAR-SPECIFIC JRNL TITL 2 LIGANDS AND THEIR COMBINATIONS. JRNL REF CELLS V. 8 2019 JRNL REFN ESSN 2073-4409 JRNL PMID 31694317 JRNL DOI 10.3390/CELLS8111392 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 67.24 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 24844 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.162 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6SSQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-SEP-19. REMARK 100 THE DEPOSITION ID IS D_1292104123. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.001700 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24860 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 67.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 11.50 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 46.4900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 4JYI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM TRI SODIUM CITRATE PH 5.5, 25 % REMARK 280 PEG 4000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.10450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.64500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.64800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.64500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.10450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.64800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, F, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 148 REMARK 465 GLY A 149 REMARK 465 SER A 150 REMARK 465 SER A 151 REMARK 465 HIS A 152 REMARK 465 HIS A 153 REMARK 465 HIS A 154 REMARK 465 HIS A 155 REMARK 465 HIS A 156 REMARK 465 HIS A 157 REMARK 465 SER A 158 REMARK 465 SER A 159 REMARK 465 GLY A 160 REMARK 465 LEU A 161 REMARK 465 VAL A 162 REMARK 465 PRO A 163 REMARK 465 ARG A 164 REMARK 465 GLY A 165 REMARK 465 SER A 166 REMARK 465 HIS A 167 REMARK 465 MET A 168 REMARK 465 GLU A 169 REMARK 465 ASN A 409 REMARK 465 SER A 410 REMARK 465 GLU A 411 REMARK 465 GLY A 412 REMARK 465 HIS A 413 REMARK 465 GLU A 414 REMARK 465 MET B 148 REMARK 465 GLY B 149 REMARK 465 SER B 150 REMARK 465 SER B 151 REMARK 465 HIS B 152 REMARK 465 HIS B 153 REMARK 465 HIS B 154 REMARK 465 HIS B 155 REMARK 465 HIS B 156 REMARK 465 HIS B 157 REMARK 465 SER B 158 REMARK 465 SER B 159 REMARK 465 ASN B 409 REMARK 465 SER B 410 REMARK 465 GLU B 411 REMARK 465 GLY B 412 REMARK 465 HIS B 413 REMARK 465 GLU B 414 REMARK 465 ARG F 629 REMARK 465 GLY F 640 REMARK 465 SER F 641 REMARK 465 GLY G 640 REMARK 465 SER G 641 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 186 CD CE NZ REMARK 470 LYS A 369 CG CD CE NZ REMARK 470 GLU A 386 CD OE1 OE2 REMARK 470 ARG B 164 CG CD NE CZ NH1 NH2 REMARK 470 SER B 166 OG REMARK 470 LYS B 186 CG CD CE NZ REMARK 470 ASP B 208 CG OD1 OD2 REMARK 470 LYS B 343 CG CD CE NZ REMARK 470 GLU B 386 CD OE1 OE2 REMARK 470 LYS F 631 CG CD CE NZ REMARK 470 GLU F 639 CG CD OE1 OE2 REMARK 470 ARG G 629 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 206 57.17 33.37 REMARK 500 ARG A 360 65.07 -117.23 REMARK 500 MET A 372 3.67 -69.82 REMARK 500 PHE B 192 95.38 -164.19 REMARK 500 ARG B 360 71.58 -111.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 754 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FLC A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 754 B 501 DBREF 6SSQ A 169 414 UNP P10826 RARB_HUMAN 176 421 DBREF 6SSQ B 169 414 UNP P10826 RARB_HUMAN 176 421 DBREF 6SSQ F 629 641 UNP Q15788 NCOA1_HUMAN 686 698 DBREF 6SSQ G 629 641 UNP Q15788 NCOA1_HUMAN 686 698 SEQADV 6SSQ MET A 148 UNP P10826 INITIATING METHIONINE SEQADV 6SSQ GLY A 149 UNP P10826 EXPRESSION TAG SEQADV 6SSQ SER A 150 UNP P10826 EXPRESSION TAG SEQADV 6SSQ SER A 151 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS A 152 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS A 153 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS A 154 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS A 155 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS A 156 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS A 157 UNP P10826 EXPRESSION TAG SEQADV 6SSQ SER A 158 UNP P10826 EXPRESSION TAG SEQADV 6SSQ SER A 159 UNP P10826 EXPRESSION TAG SEQADV 6SSQ GLY A 160 UNP P10826 EXPRESSION TAG SEQADV 6SSQ LEU A 161 UNP P10826 EXPRESSION TAG SEQADV 6SSQ VAL A 162 UNP P10826 EXPRESSION TAG SEQADV 6SSQ PRO A 163 UNP P10826 EXPRESSION TAG SEQADV 6SSQ ARG A 164 UNP P10826 EXPRESSION TAG SEQADV 6SSQ GLY A 165 UNP P10826 EXPRESSION TAG SEQADV 6SSQ SER A 166 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS A 167 UNP P10826 EXPRESSION TAG SEQADV 6SSQ MET A 168 UNP P10826 EXPRESSION TAG SEQADV 6SSQ MET A 407 UNP P10826 LEU 414 CONFLICT SEQADV 6SSQ MET B 148 UNP P10826 INITIATING METHIONINE SEQADV 6SSQ GLY B 149 UNP P10826 EXPRESSION TAG SEQADV 6SSQ SER B 150 UNP P10826 EXPRESSION TAG SEQADV 6SSQ SER B 151 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS B 152 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS B 153 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS B 154 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS B 155 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS B 156 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS B 157 UNP P10826 EXPRESSION TAG SEQADV 6SSQ SER B 158 UNP P10826 EXPRESSION TAG SEQADV 6SSQ SER B 159 UNP P10826 EXPRESSION TAG SEQADV 6SSQ GLY B 160 UNP P10826 EXPRESSION TAG SEQADV 6SSQ LEU B 161 UNP P10826 EXPRESSION TAG SEQADV 6SSQ VAL B 162 UNP P10826 EXPRESSION TAG SEQADV 6SSQ PRO B 163 UNP P10826 EXPRESSION TAG SEQADV 6SSQ ARG B 164 UNP P10826 EXPRESSION TAG SEQADV 6SSQ GLY B 165 UNP P10826 EXPRESSION TAG SEQADV 6SSQ SER B 166 UNP P10826 EXPRESSION TAG SEQADV 6SSQ HIS B 167 UNP P10826 EXPRESSION TAG SEQADV 6SSQ MET B 168 UNP P10826 EXPRESSION TAG SEQADV 6SSQ MET B 407 UNP P10826 LEU 414 CONFLICT SEQRES 1 A 267 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 267 LEU VAL PRO ARG GLY SER HIS MET GLU SER TYR GLU MET SEQRES 3 A 267 THR ALA GLU LEU ASP ASP LEU THR GLU LYS ILE ARG LYS SEQRES 4 A 267 ALA HIS GLN GLU THR PHE PRO SER LEU CYS GLN LEU GLY SEQRES 5 A 267 LYS TYR THR THR ASN SER SER ALA ASP HIS ARG VAL ARG SEQRES 6 A 267 LEU ASP LEU GLY LEU TRP ASP LYS PHE SER GLU LEU ALA SEQRES 7 A 267 THR LYS CYS ILE ILE LYS ILE VAL GLU PHE ALA LYS ARG SEQRES 8 A 267 LEU PRO GLY PHE THR GLY LEU THR ILE ALA ASP GLN ILE SEQRES 9 A 267 THR LEU LEU LYS ALA ALA CYS LEU ASP ILE LEU ILE LEU SEQRES 10 A 267 ARG ILE CYS THR ARG TYR THR PRO GLU GLN ASP THR MET SEQRES 11 A 267 THR PHE SER ASP GLY LEU THR LEU ASN ARG THR GLN MET SEQRES 12 A 267 HIS ASN ALA GLY PHE GLY PRO LEU THR ASP LEU VAL PHE SEQRES 13 A 267 THR PHE ALA ASN GLN LEU LEU PRO LEU GLU MET ASP ASP SEQRES 14 A 267 THR GLU THR GLY LEU LEU SER ALA ILE CYS LEU ILE CYS SEQRES 15 A 267 GLY ASP ARG GLN ASP LEU GLU GLU PRO THR LYS VAL ASP SEQRES 16 A 267 LYS LEU GLN GLU PRO LEU LEU GLU ALA LEU LYS ILE TYR SEQRES 17 A 267 ILE ARG LYS ARG ARG PRO SER LYS PRO HIS MET PHE PRO SEQRES 18 A 267 LYS ILE LEU MET LYS ILE THR ASP LEU ARG SER ILE SER SEQRES 19 A 267 ALA LYS GLY ALA GLU ARG VAL ILE THR LEU LYS MET GLU SEQRES 20 A 267 ILE PRO GLY SER MET PRO PRO LEU ILE GLN GLU MET MET SEQRES 21 A 267 GLU ASN SER GLU GLY HIS GLU SEQRES 1 B 267 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 267 LEU VAL PRO ARG GLY SER HIS MET GLU SER TYR GLU MET SEQRES 3 B 267 THR ALA GLU LEU ASP ASP LEU THR GLU LYS ILE ARG LYS SEQRES 4 B 267 ALA HIS GLN GLU THR PHE PRO SER LEU CYS GLN LEU GLY SEQRES 5 B 267 LYS TYR THR THR ASN SER SER ALA ASP HIS ARG VAL ARG SEQRES 6 B 267 LEU ASP LEU GLY LEU TRP ASP LYS PHE SER GLU LEU ALA SEQRES 7 B 267 THR LYS CYS ILE ILE LYS ILE VAL GLU PHE ALA LYS ARG SEQRES 8 B 267 LEU PRO GLY PHE THR GLY LEU THR ILE ALA ASP GLN ILE SEQRES 9 B 267 THR LEU LEU LYS ALA ALA CYS LEU ASP ILE LEU ILE LEU SEQRES 10 B 267 ARG ILE CYS THR ARG TYR THR PRO GLU GLN ASP THR MET SEQRES 11 B 267 THR PHE SER ASP GLY LEU THR LEU ASN ARG THR GLN MET SEQRES 12 B 267 HIS ASN ALA GLY PHE GLY PRO LEU THR ASP LEU VAL PHE SEQRES 13 B 267 THR PHE ALA ASN GLN LEU LEU PRO LEU GLU MET ASP ASP SEQRES 14 B 267 THR GLU THR GLY LEU LEU SER ALA ILE CYS LEU ILE CYS SEQRES 15 B 267 GLY ASP ARG GLN ASP LEU GLU GLU PRO THR LYS VAL ASP SEQRES 16 B 267 LYS LEU GLN GLU PRO LEU LEU GLU ALA LEU LYS ILE TYR SEQRES 17 B 267 ILE ARG LYS ARG ARG PRO SER LYS PRO HIS MET PHE PRO SEQRES 18 B 267 LYS ILE LEU MET LYS ILE THR ASP LEU ARG SER ILE SER SEQRES 19 B 267 ALA LYS GLY ALA GLU ARG VAL ILE THR LEU LYS MET GLU SEQRES 20 B 267 ILE PRO GLY SER MET PRO PRO LEU ILE GLN GLU MET MET SEQRES 21 B 267 GLU ASN SER GLU GLY HIS GLU SEQRES 1 F 13 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER SEQRES 1 G 13 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER HET 754 A 501 29 HET FLC A 502 13 HET GOL A 503 6 HET 754 B 501 29 HETNAM 754 (2E,4E,6Z)-3-METHYL-7-(5,5,8,8-TETRAMETHYL-3-PROPOXY-5, HETNAM 2 754 6,7,8-TETRAHYDRONAPHTHALEN-2-YL)OCTA-2,4,6-TRIENOIC HETNAM 3 754 ACID HETNAM FLC CITRATE ANION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 5 754 2(C26 H36 O3) FORMUL 6 FLC C6 H5 O7 3- FORMUL 7 GOL C3 H8 O3 FORMUL 9 HOH *126(H2 O) HELIX 1 AA1 TYR A 171 GLU A 190 1 20 HELIX 2 AA2 SER A 194 LEU A 198 5 5 HELIX 3 AA3 ASP A 214 ARG A 238 1 25 HELIX 4 AA4 GLY A 241 LEU A 245 5 5 HELIX 5 AA5 THR A 246 THR A 268 1 23 HELIX 6 AA6 ARG A 287 ALA A 293 1 7 HELIX 7 AA7 PHE A 295 PRO A 297 5 3 HELIX 8 AA8 LEU A 298 LEU A 310 1 13 HELIX 9 AA9 PRO A 311 GLU A 313 5 3 HELIX 10 AB1 ASP A 315 ILE A 328 1 14 HELIX 11 AB2 GLU A 337 ARG A 360 1 24 HELIX 12 AB3 HIS A 365 MET A 372 1 8 HELIX 13 AB4 MET A 372 ILE A 395 1 24 HELIX 14 AB5 PRO A 400 MET A 407 1 8 HELIX 15 AB6 THR B 174 THR B 191 1 18 HELIX 16 AB7 SER B 194 LEU B 198 5 5 HELIX 17 AB8 ASP B 214 LEU B 239 1 26 HELIX 18 AB9 GLY B 241 LEU B 245 5 5 HELIX 19 AC1 THR B 246 THR B 268 1 23 HELIX 20 AC2 ARG B 287 GLY B 294 1 8 HELIX 21 AC3 PHE B 295 PRO B 297 5 3 HELIX 22 AC4 LEU B 298 LEU B 310 1 13 HELIX 23 AC5 PRO B 311 GLU B 313 5 3 HELIX 24 AC6 ASP B 315 ILE B 328 1 14 HELIX 25 AC7 GLU B 337 ARG B 360 1 24 HELIX 26 AC8 HIS B 365 ILE B 395 1 31 HELIX 27 AC9 PRO B 400 GLU B 408 1 9 HELIX 28 AD1 LYS F 631 GLU F 639 1 9 HELIX 29 AD2 LYS G 631 GLU G 639 1 9 SHEET 1 AA1 3 TYR A 270 THR A 271 0 SHEET 2 AA1 3 THR A 276 THR A 278 -1 O THR A 276 N THR A 271 SHEET 3 AA1 3 THR A 284 ASN A 286 -1 O LEU A 285 N MET A 277 SHEET 1 AA2 3 TYR B 270 THR B 271 0 SHEET 2 AA2 3 THR B 276 THR B 278 -1 O THR B 276 N THR B 271 SHEET 3 AA2 3 THR B 284 ASN B 286 -1 O LEU B 285 N MET B 277 SITE 1 AC1 14 PHE A 192 ALA A 225 LEU A 262 ILE A 263 SITE 2 AC1 14 ARG A 269 PHE A 279 SER A 280 PHE A 295 SITE 3 AC1 14 LEU A 298 VAL A 302 GLY A 384 VAL A 388 SITE 4 AC1 14 LEU A 391 HOH A 615 SITE 1 AC2 11 GLU A 336 GLU A 337 PRO A 338 THR A 339 SITE 2 AC2 11 PRO A 401 HOH A 609 HOH A 625 HIS G 630 SITE 3 AC2 11 LYS G 631 ILE G 632 ARG G 635 SITE 1 AC3 6 THR A 203 SER A 205 GLY A 216 HOH A 638 SITE 2 AC3 6 ARG G 629 HIS G 630 SITE 1 AC4 14 PHE B 192 PHE B 221 LEU B 259 LEU B 262 SITE 2 AC4 14 ILE B 263 ILE B 266 ARG B 269 PHE B 279 SITE 3 AC4 14 SER B 280 PHE B 295 VAL B 388 LEU B 391 SITE 4 AC4 14 MET B 407 HOH B 610 CRYST1 58.209 85.296 109.290 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017179 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011724 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009150 0.00000